Exploring a program to prevent postpartum depression in new mothers
The ROSE Scale-Up Study: Informing a decision about ROSE as universal postpartum depression prevention
This study is looking at a program called ROSE that helps all new moms by offering support and resources to prevent postpartum depression, so if you're a new mother, you can benefit from this program to help keep your mental health in check during this important time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10904847 on NIH RePORTER |
What this research studies
This research investigates the ROSE program, which aims to prevent postpartum depression (PPD) by providing support and resources to all new mothers, rather than just those identified as at risk. The approach focuses on implementing this program universally in healthcare settings, making it accessible to a broader population. By integrating ROSE into standard care practices, the study seeks to evaluate its effectiveness in reducing the incidence of PPD among new mothers. Participants will receive evidence-based interventions designed to support their mental health during the postpartum period.
Who could benefit from this research
Good fit: Ideal candidates for this research are new mothers, particularly those who have recently given birth, regardless of their risk factors for postpartum depression.
Not a fit: Patients who are not new mothers or those who are not within the postpartum period may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of postpartum depression among new mothers, leading to better mental health outcomes for both mothers and their infants.
How similar studies have performed: Previous studies have shown that similar universal prevention approaches can effectively reduce postpartum depression rates, indicating a promising avenue for this research.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Johnson, Jennifer E — Michigan State University
- Study coordinator: Johnson, Jennifer E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.